News Releases
2010
June 29, 2010 - Covalon Secures National Research Council Funding for Antimicrobial Coating of Orthopaedic Implants
June 22, 2010 - Covalon Announces Multi-year Agreement with Large Medical Distributor
June 15, 2010 - Covalon Announces Expanded Agreement
May 28, 2010 - New Covalon CEO Provides Shareholder Update and Releases Second Quarter Results
April 8, 2010 - Covalon Announces Resignation of Director
April 7, 2010 - Covalon Reschedules Annual and Special Meeting for Wednesday, May 19, 2010
April 5, 2010 - Covalon appoints Brian Pedlar as CEO
January 28, 2010 - Covalon announces latest financial results
January 15, 2010 - Covalon announces new board members
2009
October 28, 2009 - Covalon Investor Update
October 26, 2009 - Covalon announces development agreement with CareFusion Corporation - Cardinal Health's major spinoff
October 23, 2009 - Covalon appoints William Jackson as Chief Financial Officer and Board Director
October 22, 2009 - Covalon and Amsino International advance joint activities
October 20, 2009 - Covalon Signs License Agreement with Bard
August 28, 2009 - Covalon Releases Third Quarter 2009 Financial Results
May 28, 2009 - Covalon releases Second Quarter 2009 Financial Results
May 4, 2009 - Covalon Announces Significant Cost Reductions
April 24, 2009 - Covalon Technologies and Amsino International Announce Strategic Alliance
March 30, 2009 - Covalon Technologies appoints Abe Schwartz as Advisor to the Company
March 4, 2009 - Covalon Grants Options
February 27, 2009 - Covalon Technologies Ltd. Announces First Quarter Financial Results
February 27, 2009 - Covalon Technologies Grants Options
January 26, 2009 - Covalon Technologies Ltd. Announces Fiscal 2008 Year End Financial Results
January 12, 2009 - Covalon Welcomes New Board Member
2008
December 17, 2008 - Covalon Awarded CE Marking for Collagen Dressings in the European Union
October 27, 2008 - Covalon CEO speaks at Medical Devices Symposium
October 17, 2008 - Covalon Grant of Options
September 29, 2008 - Covalon announces appointment of new CFO
August 22, 2008 - Covalon Releases 2008 Q3 Results
July 8, 2008 - Covalon Achieves Significant Progress in Development Agreement with One of the World's Largest Vascular Access Companies
June 19, 2008 - Covalon Technologies Ltd. selected as one of the TSX Venture’s 50 top performers for the second consecutive year
May 29, 2008 - Covalon Releases 2008 Q2 Financial Results
May 21, 2008 - Covalon Enters into Another Development Agreement for Its Antimicrobial Coating on Percutaneous Urinary Catheters
May 20, 2008 - Covalon Receives Health Canada Approval
April 28, 2008 - Covalon’s Antimicrobial Coating on Foley Catheters Reduces Infections to “Zero” in Six Month Hospital Study
March 31, 2008 - Covalon Grant of Options
March 27, 2008 - Covalon Receives Canadian Patent for Drug Delivery via Therapeutic Hydrogels
March 11, 2008 - Covalon Welcomes Newest Board Members
January 28, 2008 - Covalon Releases 2007 and 2008 Q1 Financial Results
2007
December 17, 2007 - Covalon announces appointment of new CFO
November 20, 2007 - Covalon Achieves Important Milestone in its Cell-based Gene Therapy for Treating Congestive Heart Failure and Tissue Regeneration
November 19, 2007 - Orthopaedic Trauma Association funds research on the use of
Covalon’s Antimicrobial Coating for Orthopaedic Trauma Implants
November 12, 2007 - Covalon Announces New Collagen-based Wound Dressings
that Restore a More Normal Healing Environment
October 5, 2007 - Covalon accounces new Chief Operating Officer
September 27, 2007 - Covalon receives $11,642,110 from exercise of warrants
August 29, 2007 - Covalon Q3 Results
August 16, 2007 - Covalon advances its antimicrobial coating to be non-blood-clotting for venous access catheters and devices
June 26, 2007 - Covalon Technologies Ltd. selected as one of 50 top performers listed on the TSX Venture
May 17, 2007 - Covalon Q2 Results
April 18, 2007 - Covalon Announces Appointment of Mr. Brad Williams as Independent Chairman of the Board
March 27, 2007 - Covalon Discloses Details of Deal with Smith & Nephew
March 27, 2007 - Covalon Grant of Options
March 19, 2007 - Covalon announces worldwide agreement with Smith & Nephew
March 01, 2007 - Covalon Interim Financial Statements,
Three months ended December 31, 2006
January 18, 2007 - Covalon pursues the orthopedic market with its antimicrobial coating on orthopedic implants
2006
November 10, 2006 - Covalon receives high value US reimbursement codes for its wound dressings
October 30, 2006 - Covalon licences EPAS1 technology from The University of Texas Southwestern Medical Center at Dallas
October 24, 2006 - Covalon Announces Completed Acquisition of Perfusion Therapeutics' Gene Therapy Technology
August 14, 2006 - Covalon takes action against former CEO
August 08, 2006 - Press Release
May 18, 2006 - New Covalon Board prepares the company for growth
April 26, 2006 - FDA approval received on Covalon’s new Collagran and Collagran Ag
advanced wound dressings with matrix metalloprotease (MMP) inhibiting activity
April 04, 2006 - Covalon applies for FDA approval for its "Collagran Ag" collagen antimicrobial silver wound dressing
March 22, 2006 - Covalon Announces Closing of $6.8 million Private Placement
March 01, 2006 - Covalon Interim Financial Statement, three months ended December 31, 2005
February 27, 2006 - Covalon receives patents in France, Germany and UK for Drug delivery via therapeutic hydrogels
February 22, 2006 - Covalon announces underwritten private placement
February 20, 2006 - FDA approval received on Covalon silver ion releasing coating
February 07, 2006 - Covalon receives FDA approval for CovaClear Ag™
January 27, 2006 - Covalon earnings for the year ending September 30, 2005
January 16, 2006 - Covalon receives freedom to operate US opinion letters relating to Covalon's vascular wrap technology and vascular graft coating technology for delivery of Sirolimus
January 12, 2006 - Covalon enters into significant international distribution agreement for new antimicrobial and regular collagen-based wound dressings
January 10, 2006 - Covalon receives Health Canada approval for its antimicrobial coating on Foley catheters
2005
December 05, 2005 - Covalon Receives Approval for Sale of its Three Wound Dressings in Canada
October 12, 2005 - Covalon applies for FDA approval for its hydrated collagen antimicrobial silver wound dressing
October 03, 2005 - Covalon significantly increases sales orders for fourth quarter 2005
September 29, 2005 - Covalon receives European patent for drug delivery via therapeutic hydrogels
September 08, 2005 - Jacques Lemmetti appointed Chairman of the Board at Covalon
September 07, 2005 - Jacques Lemmetti appointed Chairman of the Board at Covalon
September 06, 2005 - Covalon recommended for ISO 13485:2003 certification
August 17, 2005 - Covalon and Medline Industries apply for FDA approval for Covalon's silver ion antimicrobial coating
August 04, 2005 - Covalon Launches Collagen Wound Dressings
July 07, 2005 - Covalon Technologies Ltd.: Grant of Options
June 08, 2005 - Covalon Receives FDA Approval for its Antimicrobial Silver Collagen Wound Dressing.
May 02, 2005 - Covalon Receives European Patent for Drug Delivery Method Using Liposomes within Therapeutic Collagen-based Hydrogels
April 29, 2005 - Covalon receives FDA approval for its collagen scaffold for wound dressing applications
April 28, 2005 - Covalon Receives First Milestone Payment from Hartmann-Conco
April 21, 2005 - Covalon Successfully Cultures Cells Using its Collagen-based Scaffold for Tissue Regeneration
April 20, 2005 - Covalon Receives USA Patent and European Patent Certificate for Anti-Microbial Technology Applied to Implantable Medical Devices
April 11, 2005 - Covalon Signs US Licensing Letter of Intent for its Anti-microbial Coating Technology
April 04, 2005 - Covalon Responds to FDA's Request for Further Information
March 31, 2005 - Exercise of Warrants and Options in Covalon Technologies Ltd.
February 11, 2005 - Covalon signs US Distribution Agreement with Hartmann-Conco
February 9, 2005 - Covalon enters financial advisory agreement
January 14, 2005 - Covalon Technologies Ltd.
2004
December 29, 2004 - Acquisition of Securities of Covalon Technologies Ltd.'Formerly Seder Capital Corp.'
December 21, 2004 - Covalon Technologies Ltd. announces the Closing of Qualifying Transaction
June 29, 2004 - Acquisition of Securities of Covalon Technologies Ltd.
